- Home
- HOV vs KURA Comparison
HOV vs KURA Comparison
Compare HOV & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOV
- KURA
- Stock Information
- Founded
- HOV 1959
- KURA 2014
- Country
- HOV United States
- KURA United States
- Employees
- HOV N/A
- KURA N/A
- Industry
- HOV Homebuilding
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HOV Consumer Discretionary
- KURA Health Care
- Exchange
- HOV Nasdaq
- KURA Nasdaq
- Market Cap
- HOV 606.2M
- KURA 561.9M
- IPO Year
- HOV N/A
- KURA N/A
- Fundamental
- Price
- HOV $110.29
- KURA $6.13
- Analyst Decision
- HOV Sell
- KURA Strong Buy
- Analyst Count
- HOV 2
- KURA 12
- Target Price
- HOV $120.00
- KURA $24.50
- AVG Volume (30 Days)
- HOV 280.4K
- KURA 1.4M
- Earning Date
- HOV 08-21-2025
- KURA 08-07-2025
- Dividend Yield
- HOV N/A
- KURA N/A
- EPS Growth
- HOV N/A
- KURA N/A
- EPS
- HOV 28.18
- KURA N/A
- Revenue
- HOV $3,062,436,000.00
- KURA $67,991,000.00
- Revenue This Year
- HOV $0.00
- KURA $125.04
- Revenue Next Year
- HOV $2.50
- KURA $83.75
- P/E Ratio
- HOV $3.84
- KURA N/A
- Revenue Growth
- HOV 7.85
- KURA N/A
- 52 Week Low
- HOV $81.15
- KURA $5.41
- 52 Week High
- HOV $240.34
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- HOV 59.03
- KURA 51.23
- Support Level
- HOV $113.72
- KURA $5.65
- Resistance Level
- HOV $125.60
- KURA $6.51
- Average True Range (ATR)
- HOV 6.60
- KURA 0.27
- MACD
- HOV 0.86
- KURA 0.06
- Stochastic Oscillator
- HOV 65.27
- KURA 59.68
About HOV Hovnanian Enterprises Inc.
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations . The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments; Northeast which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia and West Virginia; Southeast which includes Florida, Georgia and South Carolina; and West which includes Arizona, California and Texas. The firm generates maximum revenue from West Segment.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.